Bone disorder therapeutics - Emisphere/Roche

Drug Profile

Bone disorder therapeutics - Emisphere/Roche

Latest Information Update: 09 May 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Emisphere Technologies; Roche
  • Class Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Bone disorders

Most Recent Events

  • 15 Feb 2006 Roche has initiated a clinical trial to evaluate a second small molecule compound for Bone disorders
  • 05 Jul 2005 Phase-I clinical trials in Bone disorders in USA (PO)
  • 23 Nov 2004 Preclinical trials in Bone disorders in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top